Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression

Clinical Cancer Research

Volumn 15, Issue 10, 2009, Pages 3287-3296

  Lu, Xuefeng ^a,e   Feng, Xiujing ^a,e   Man, Xiaobo ^b   Yang, Guang ^a,e   Tang, Liang ^b   Du, Dan ^a,e   Zhang, Fan ^a   Yuan, Haixin ^a,e   Huang, Qin ^a,e   Zhang, Zhe ^a   Liu, Yinkun ^c   Strand, Dennis ^d   Chen, Zhengjun ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; HUGL 1 PROTEIN; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CARCINOMA CELL; CELL MIGRATION; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE ANALYSIS; TISSUE DIFFERENTIATION; TUMOR SUPPRESSOR GENE; TUMOR VOLUME; WESTERN BLOTTING; WOUND HEALING;

ADULT; AGED; ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 66149186859     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-08-2078     Document Type: Article

References (43)

1. Henrique D, Schweisguth F. Cell polarity: the ups and downs of the Par6/aPKC complex. Curr Opin Genet Dev 2003;13:341-350 (Pubitemid 36897796)
2. Brazil DP, Hemmings BA. Cell polarity: scaffold proteins par excellence. Curr Biol 2000;10:R592-94.
3. Rolls MM, Doe CQ. Cell polarity: from embryo to axon. Nature 2003;421:905-906
4. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54. (Pubitemid 33741880)
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)
6. Aranda V, Haire T, Nolan ME, et al. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 2006;8:1235-1245
7. Kim M, Datta A, Brakeman P, Yu W, Mostov KE. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3β in 3D epithelial morphogenesis. J Cell Sci 2007;120:2309-2317 (Pubitemid 47225934)
8. Hubbard AL, Wall DA, Ma A. Isolation of rat hepatocyte plasma membranes: I. Presence of the three major domains. J Cell Biol 1983;96:217-229
9. Stamatoglou SC, Hughes RC. Cell adhesionmolecules in liver function and pattern formation. Faseb J 1994;8:420-427 (Pubitemid 24985951)
10. Van Hengel J, D'Hooge P, Hooghe B, et al . Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficientm ouse liver. Gastroenterology 2008;134:781-792
11. Vasioukhin V. Lethal giant puzzle of Lgl. Dev Neurosci 2006;28:13-24. (Pubitemid 43320047)
12. Woods DF, Bryant PJ. Molecular cloning of the lethal(1)discs large-1 oncogene of Drosophila. Dev Biol 1989;134:222-235
13. Bilder D, Li M, Perrimon N. Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors. Science 2000;289:113-116 (Pubitemid 30463303)
14. Bilder D, Perrimon N. Localization of apical epithel ial determinants by the basolateral PDZ protein Scribble. Nature 2000;403:676-680 (Pubitemid 30104011)
15. Gateff E. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 1978;200:1448-1459 (Pubitemid 8386753)
16. Woodhouse E, Hersperger E, Shearn A. Growth, metastasis, and invasiveness of Drosophila tumors caused by mutations in specific tumor suppressor genes. Dev Genes Evol 1998;207:542-550 (Pubitemid 28134887)
17. Pagliarini RA, Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003;302:1227-1231 (Pubitemid 37421030)
18. Strand D, Unger S, Corvi R, et al. A human homologue of the Drosophila tumour suppressor gene l(2)gl maps to 17p11.2-12 and codes for a cytoskeletal protein that associates with nonmuscle myosin II heavy chain. Oncogene 1995;11:291-301.
19. Grifoni D, Garoia F, Schimanski CC, eta l. The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo. Oncogene 2004;23:8688-8694
20. Schimanski CC, Schmitz G, Kashyap A, et al. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 2005;24:3100-3109 (Pubitemid 40695079)
21. Kuphal S, Wallner S, Schimanski CC, et al. Expression of Hugl-1 is strongly reduced in malignantmelanoma. Oncogene 2006;25:103-110
22. Tsuruga T, Nakagawa S, Watanabe M, et al. Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer. Oncol Res 2007;16:431-435
23. Venables JP. Aberrant and alternative splicing in cancer. Cancer Res 2004;64:7647-7654 (Pubitemid 39446889)
24. Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462-503.
25. Bieche I, Lidereau R. Increased level of exon 12 alternatively spliced BRCA2 transcripts in tumor breast tissue compared with normal tissue. Cancer Res 1999;59:2546-2550 (Pubitemid 29269095)
26. Pritchard-Jones K. The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis. Pediatr Nephrol 1999;1:620-625 (Pubitemid 29403485)
27. Lukas J, Gao DQ, Keshmeshian M, et al. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer. Cancer Res 2001;61:3212-3219
28. Kalnina Z, Zayakin P, Silina K, et al. Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 2005;42:342-357 (Pubitemid 40271278)
29. Hogg A, Bia B, Onadim Z, Cowell JK. Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma. Proc Natl Acad Sci U S A 1993;90:7351-7355 (Pubitemid 23222448)
30. Bartel F, Taubert H, Harris LC. Alternative and aberrants plicing of MDM2 mRNA in human cancer. Cancer Cell 2002;2:9-15. (Pubitemid 41043984)
31. Streisinger G, Okada Y, Emrich J, et al. Frame-shift mutations and the genetic code. This paper is dedicated to Professor Theodosius Dobzhansky on the occasion of his 66th birthday. Cold Spring Harb Symp Quant Biol 1966;31:77-84.
32. Shinozaki A, Arahata K, Tsukahara T. Changes in pre-mRNA splicing factors during neural differentiation in P19 embryonal carcinoma cells. Int J Biochem Cell Biol 1999;31:1279-1287 (Pubitemid 29486709)
33. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999;96:307-310 (Pubitemid 29077583)
34. Green RE, Lewis BP, Hillman RT, et al. Wide-spread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes. Bioinformatics 2003;19 Suppl 1:i118-121.
35. Chen S, Spiegelberg BD, Lin F, Dell EJ, Hamm HE. Interaction of Gαγ; with RACK1 and other WD40 repeatprot eins. J Mol Cell Cardiol 2004;37:399-406. (Pubitemid 38953368)
36. Betschinger J, Eisenhaber F, Knoblich JA. Phosphorylation- induced autoinhibition regulates the cytoskeletal protein Lethal (2) giant larvae. Curr Biol 2005;15:276-282
37. Kim YS, Kim YK, Park JM, et al. Disruption of protein-protein interaction in the Mgl-1 oncoprotein. Oncol Rep 2006;16:795-800.
38. Hattendorf DA, Andreeva A, Gangar A, Brennwald PJ, Weis WI. Structure of the yeast polarity protein Sro7 reveals a SNARE regulatory mechanism. Nature 2007;446:567-571 (Pubitemid 46514726)
39. Kim YK, Kim YS, Baek KH. The WD-40 repeat motif of Lgl tumor suppressor proteins associated with salt tolerance and temperature sensitivity. Biochem Biophys Res Commun 2005;331:922-928 (Pubitemid 40692449)
40. Zhan L, Rosenberg A, Bergami KC, et al. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008;135:865-878
41. Si MS, Amersi F, Golish SR, et al. Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survival. Am Surg 2003;69:879-885
42. Nakashima Y, Nakashima O, Tanaka M, et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003;26:142-147
43. Mercatante D, Kole R. Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol Ther 2000;85:237-243 (Pubitemid 30160793)